Skip to content

Multicenter Registration Study on Allergic Bronchopulmonary Aspergillosis

A Multicenter Retrospective Cohort Study on Allergic Bronchopulmonary Aspergillosis

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06645210
Enrollment
300
Registered
2024-10-16
Start date
2024-10-15
Completion date
2026-01-31
Last updated
2024-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Bronchopulmonary Aspergillosis

Keywords

cohort study

Brief summary

To understand the current diagnosis and treatment status of ABPA patients, observe their clinical characteristics, prognosis, and treatment outcomes, and identify the relevant factors for poor prognosis in patients.

Interventions

None listed

Sponsors

First Affiliated Hospital of Guangxi Medical University
CollaboratorOTHER
Guangzhou Institute of Respiratory Disease
CollaboratorOTHER
Tongji Hospital
CollaboratorOTHER
Nanfang Hospital, Southern Medical University
CollaboratorOTHER
The First Affiliated Hospital with Nanjing Medical University
CollaboratorOTHER
Qianfoshan Hospital
CollaboratorOTHER
The First Affiliated Hospital of Shanxi Medical University
CollaboratorOTHER
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
CollaboratorOTHER
West China Hospital
CollaboratorOTHER
Second Affiliated Hospital of Xi'an Jiaotong University
CollaboratorOTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
CollaboratorOTHER
Xiangya Hospital of Central South University
CollaboratorOTHER
Peking Union Medical College Hospital
CollaboratorOTHER
Ruijin Hospital
CollaboratorOTHER
Peking University Third Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

Meeting the diagnosis of ABPA according to the ABPA diagnostic criteria specified by the ISHAM-ABPA working group in 2024

Exclusion criteria

ABPA patients who are not first diagnosed in the center

Design outcomes

Primary

MeasureTime frameDescription
Clinical classification and treatment response criteria for ABPA1 year1. Acute ABPA 2. Response 3. Remission 4. Treatment-dependent ABPA 5. Advanced ABPA

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026